Our Business
AI Biopharma
AI across every step, from molecule discovery to drug approval
AI-driven drug R&D end to end: early molecule discovery, clinical research, virtual clinical studies and drug development — a new paradigm beyond traditional pharma R&D.
HeChoo AI Biopharma rebuilds the drug R&D pathway with artificial intelligence — covering early molecule discovery, clinical research, virtual clinical studies and final drug development, a fundamentally different paradigm from traditional pharma R&D.
Our TrailAi platform is the core vehicle: AI screens and optimizes candidate molecules, virtual clinical studies predict safety and efficacy before real trials begin, and an AI clinical research platform accelerates trial execution and data analysis — cutting both cost and development time.
10x
Screening efficiency
40%
Shorter clinical timelines
120+
AI-supported studies
Four pillars, one ecosystem
AI Early Molecule Discovery
Generative models and multi-omics data power target discovery, molecule generation and candidate compound screening.
Virtual Clinical Studies
Virtual populations and simulation models predict safety, efficacy and protocol risk before real trials start.
AI Clinical Research (TrailAi)
TrailAi powers protocol design, intelligent patient matching and clinical data analysis.